Product Overview
Byakangelicol | T6S0077 | TargetMol Chemicals
CAS: 26091-79-2
Smiles: [H][C@]1(COc2c3occc3c(OC)c3ccc(=O)oc23)OC1(C)C
Formula: C17H16O6
Pathway: Immunology/Inflammation|||Neuroscience
Target: COX
Receptor: N/A
Bioactivity: 1. Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. 2. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 enzyme, thus it may have therapeutic potential as an anti-inflammatory drug on airway inflammation.
Molecular Weight: 316, 309
